Schroder Investment Management Group Ocugen, Inc. Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.34 - $4.72 $839,844 - $1.69 Million
-358,908 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.38 - $15.67 $1.57 Million - $5.62 Million
358,908 New
358,908 $1.63 Million
Q2 2021

Aug 13, 2021
SELL
$5.52 - $15.68 $720,238 - $2.05 Million
-130,478 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.66 - $15.81 $216,593 - $2.06 Million
130,478 New
130,478 $886,000

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $169M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email